Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker WTW
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 3, 2026 | WTW Willis Towers Watson Public Limited Company | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2026 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 29, 2026 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 30, 2026 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 30, 2026 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 21, 2026 | WTW Willis Towers Watson Public Limited Company | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 30, 2026 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 30, 2026 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 3, 2026 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 3, 2026 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 27, 2026 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 9, 2026 | WTW Willis Towers Watson Public Limited Company | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 9, 2026 | WTW Willis Towers Watson Public Limited Company | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 22, 2025 | WTW Willis Towers Watson Public Limited Company | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 22, 2025 | WTW Willis Towers Watson Public Limited Company | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 16, 2025 | WTW Willis Towers Watson Public Limited Company | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 10, 2025 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 31, 2025 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K/A | 8-K ↗ |
| Oct 30, 2025 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 30, 2025 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 20, 2025 | WTW Willis Towers Watson Public Limited Company | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Oct 20, 2025 | WTW Willis Towers Watson Public Limited Company | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 31, 2025 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 31, 2025 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 20, 2025 | WTW Willis Towers Watson Public Limited Company | 8.01 Other Events | 8-K | 8-K ↗ |
| May 20, 2025 | WTW Willis Towers Watson Public Limited Company | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 24, 2025 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 24, 2025 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 3, 2025 | WTW Willis Towers Watson Public Limited Company | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 4, 2025 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 4, 2025 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 2, 2025 | WTW Willis Towers Watson Public Limited Company | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 31, 2024 | WTW Willis Towers Watson Public Limited Company | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 31, 2024 | WTW Willis Towers Watson Public Limited Company | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
34 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:41 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances